Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

João Franco Machado

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Dalton Transactions (Cambridge, England : 2003)|February 2, 2022
Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy?João Franco Machado, Tânia S Morais
Molecules (Basel, Switzerland)|June 2, 2021
Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer CellsJoão Franco Machado, João D G Correia, Tânia S Morais
Molecules (Basel, Switzerland)|December 26, 2018
Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and TheranosticsJoão Franco Machado, Rúben D Silva, Rita Melo, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Synthesis and Evaluation of Cytotoxic Activity of RuCp(II) Complexes Bearing (Iso)nicotinic Acid Based LigandsBárbara Marques, Diogo M Engrácia, João Franco Machado, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Ultrasonication Improves Solid Phase Synthesis of Peptides Specific for Fibroblast Growth Factor Receptor and for the Protein-Protein Interface RANK-TRAF6Rúben D M Silva, João Franco Machado, Kyle Gonçalves, et al.
Dalton Transactions (Cambridge, England : 2003)|April 22, 2020
Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancerJoão Franco Machado, Miguel Machuqueiro, Fernanda Marques, et al.
Dalton Transactions (Cambridge, England : 2003)|August 26, 2020
New copper(I) complexes selective for prostate cancer cellsJoão Franco Machado, Diogo Sequeira, Fernanda Marques, et al.
Inorganic Chemistry|March 19, 2024
Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer AgentsJoão Franco Machado, Sandra Cordeiro, Joana N Duarte, et al.
Chemmedchem|April 25, 2023
Copper(I)-Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic ActivityJoão Franco Machado, Fernanda Marques, Teresa Pinheiro, et al.
Dalton Transactions (Cambridge, England : 2003)|April 4, 2024
Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancerJoão Franco Machado, Marco Sá, Inês Pires, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Dalton Transactions (Cambridge, England : 2003)|February 2, 2022
Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy?João Franco Machado, Tânia S Morais
Molecules (Basel, Switzerland)|June 2, 2021
Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer CellsJoão Franco Machado, João D G Correia, Tânia S Morais
Molecules (Basel, Switzerland)|December 26, 2018
Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and TheranosticsJoão Franco Machado, Rúben D Silva, Rita Melo, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Synthesis and Evaluation of Cytotoxic Activity of RuCp(II) Complexes Bearing (Iso)nicotinic Acid Based LigandsBárbara Marques, Diogo M Engrácia, João Franco Machado, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Ultrasonication Improves Solid Phase Synthesis of Peptides Specific for Fibroblast Growth Factor Receptor and for the Protein-Protein Interface RANK-TRAF6Rúben D M Silva, João Franco Machado, Kyle Gonçalves, et al.
Dalton Transactions (Cambridge, England : 2003)|April 22, 2020
Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancerJoão Franco Machado, Miguel Machuqueiro, Fernanda Marques, et al.
Dalton Transactions (Cambridge, England : 2003)|August 26, 2020
New copper(I) complexes selective for prostate cancer cellsJoão Franco Machado, Diogo Sequeira, Fernanda Marques, et al.
Inorganic Chemistry|March 19, 2024
Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer AgentsJoão Franco Machado, Sandra Cordeiro, Joana N Duarte, et al.
Chemmedchem|April 25, 2023
Copper(I)-Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic ActivityJoão Franco Machado, Fernanda Marques, Teresa Pinheiro, et al.
Dalton Transactions (Cambridge, England : 2003)|April 4, 2024
Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancerJoão Franco Machado, Marco Sá, Inês Pires, et al.
Pageof 1